Literature DB >> 9987018

CaMKII-dependent phosphorylation of NR2A and NR2B is decreased in animals characterized by hippocampal damage and impaired LTP.

A Caputi1, F Gardoni, M Cimino, L Pastorino, F Cattabeni, M Di Luca.   

Abstract

The calcium-calmodulin-dependent protein kinase II (CaMKII) subserves activity-dependent plasticity in central neurons. To examine in vivo the implication of CaMKII activity in synaptic plasticity, we used an animal model characterized by developmentally induced targeted neuronal ablation within the cortex and the hippocampus, and showing, at presynaptic level, molecular alterations leading to facilitation of glutamate release in hippocampal synapses (methylazoxymethanol-treated rats, MAM-rats). We report here that at the postsynaptic side, the activity of CaMKII is markedly decreased in MAM-rats when compared to controls, although the concentration of the enzyme in Post Synaptic Density (PSD) is not altered. This effect is confined to PSD-associated CaMKII, as enzyme activity tested in the soluble fraction is unchanged in MAM-rats. In addition, the decreased activity is not due to inhibition by autophosphorylation in specific sites within the calmodulin-binding domain, as preincubation with purified phosphatases 1 and 2A failed to restore CaMKII activity in PSD of MAM-rats. The CaMKII-dependent phosphorylation of NR2A/B subunits of NMDA receptor is lower in MAM-rats when compared to controls (51.77 +/- 7.39% of controls level), as revealed in back-phosphorylation experiments. In addition, a treatment able to restore long-term potentiation (LTP) in hippocampal slices from MAM-rats, e.g. exposure to D-serine, is able to restore CaMKII activity to the control value.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987018     DOI: 10.1046/j.1460-9568.1999.00414.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Protein kinase C promotes N-methyl-D-aspartate (NMDA) receptor trafficking by indirectly triggering calcium/calmodulin-dependent protein kinase II (CaMKII) autophosphorylation.

Authors:  Jing-Zhi Yan; Zhuo Xu; Si-Qiang Ren; Bin Hu; Wen Yao; Shan-Hui Wang; Su-Yi Liu; Wei Lu
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

2.  Glycine induces bidirectional modifications in N-methyl-D-aspartate receptor-mediated synaptic responses in hippocampal CA1 neurons.

Authors:  Xiao-Yan Zhang; Fang Ji; Ning Wang; Lin-Lin Chen; Tian Tian; Wei Lu
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

Review 3.  Estradiol and the relationship between dendritic spines, NR2B containing NMDA receptors, and the magnitude of long-term potentiation at hippocampal CA3-CA1 synapses.

Authors:  Caroline C Smith; Lindsey C Vedder; Lori L McMahon
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

Review 4.  Roles of Phosphorylation of N-Methyl-D-Aspartate Receptor in Chronic Pain.

Authors:  Liangyu Pan; Tiansheng Li; Rui Wang; Weiheng Deng; Huangsheng Pu; Meichun Deng
Journal:  Cell Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.046

5.  Myosin IIb-dependent Regulation of Actin Dynamics Is Required for N-Methyl-D-aspartate Receptor Trafficking during Synaptic Plasticity.

Authors:  Yunfei Bu; Ning Wang; Shaoli Wang; Tao Sheng; Tian Tian; Linlin Chen; Weiwei Pan; Minsheng Zhu; Jianhong Luo; Wei Lu
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

6.  Hippocampal synaptic plasticity involves competition between Ca2+/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor.

Authors:  F Gardoni; L H Schrama; A Kamal; W H Gispen; F Cattabeni; M Di Luca
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  Expression of ionotropic glutamate receptors in the retina of the rdta transgenic mouse.

Authors:  L O Liu; A Laabich; A Hardison; N G Cooper
Journal:  BMC Neurosci       Date:  2001-05-23       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.